ArticleFrontiers in medicine2026
Multimodal breast cancer diagnosis using feature fusion and deep learning.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer is one of the leading health problems in the world, and the challenge lies in the fact that its diagnosis at the earliest possible and accurate rate is the main factor to guarantee a successful patient outcome. The traditional deep learning (DL) frameworks usually utilize data from a single modality at a time and, therefore, are not capable of addressing the complexity and heterogeneity of the disease, particularly when data are unavailable or incomplete. Methods: To address these constraints, a multimodal breast cancer diagnosis model is presented that consists of attention-based transformers to achieve efficient modality specific feature extraction, the modified mantissa search (MMS) algorithm to remove irrelevant features, and the American zebra optimization (AZO) algorithm to dynamically and efficiently combine features. Final classification is then performed using a lightweight convolutional neural network (LCNN) to avoid compromising diagnostic accuracy. Results and Discussion: The proposed model is highly generalizable and resilient to missing modalities, achieving 98.958, 97.37, and 99.438% accuracy on Mammographic Image Analysis Society (MIAS), BreakHis, and combined multimodal datasets, respectively. These findings reveal their usefulness and strength in clinical diagnostic cases with a variety of imaging data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.